Cytosorbents Corporation CTSO
4.75 USD +0.15 (+3.22%)
Nov 6, 2026, 3:03 PM EST
4.56 Day range 5.32
2.84 52-week range 17.00
- YTD
- -62.85%
- 1 year
- -66.56%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 37.06M | 35.59M | 31.08M | 34.69M | 43.17M | |
| 37.06M | 35.59M | 31.08M | 34.69M | 43.17M | |
| 10.57M | 10.71M | 9.13M | 13.96M | 11.05M | |
| 26.49M | 24.89M | 21.95M | 20.73M | 32.12M | |
| 41.24M | 41.34M | 53.90M | 52.25M | 54.86M | |
| 5.08M | 7.61M | 15.59M | 15.12M | 16.38M | |
| 35.65M | 33.73M | 38.31M | 37.14M | 38.48M | |
| -14.75M | -16.45M | -31.95M | -31.52M | -22.74M | |
| 2.61M | 1.40M | 157.89K | -132.60K | -28.01K | |
| -401.00K | -1.69M | -813.74K | -1.09M | -736.00K | |
| -8.20M | -20.72M | -29.25M | -32.81M | -24.56M | |
| -8.20M | -20.72M | -29.25M | -32.81M | -24.56M | |
| -8.20M | -20.72M | -29.25M | -32.81M | -24.56M | |
| -8.20M | -20.72M | -29.25M | -32.81M | -24.56M | |
| -2.60 | -7.60 | -13.00 | -15.00 | -11.40 | |
| -2.60 | -7.60 | -13.00 | -15.00 | -11.40 | |
| -2.60 | -7.60 | -13.00 | -15.00 | -11.40 | |
| -5.99M | -21.01M | -29.90M | -34.04M | -25.32M | |
| -5.99M | -21.01M | -29.90M | -34.04M | -25.32M | |
| 3.11M | 2.72M | 2.23M | 2.18M | 2.17M | |
| 3.11M | 2.72M | 2.23M | 2.18M | 2.17M |